COVERED SERVICES AND PROCEDURES
– Facet joint interventions include intraarticular (IA) injections, medial branch blocks (MBB), radiofrequency ablations (RFA), and facet cyst rupture/aspiration.
– Covered CPT/HCPCS codes include 64490-64495 for facet joint injections with fluoroscopy or CT guidance; 64633-64636 for thermal neurolytic facet joint nerve destruction; ultrasound-guided injections (0213T-0218T) and posterior intrafacet implant placements (0219T-0222T) are not covered.
– Only cervical/thoracic or lumbar/sacral facet procedures are covered; sacral injections, sacroiliitis, epidural, or other spinal procedures are excluded.
– Facet joint levels are counted by joints injected, not nerves; bilateral injections are considered single levels reported with modifier 50.
– One to two levels, unilateral or bilateral, allowed per session per spinal region; three or more levels per session are not covered.
– Diagnostic and therapeutic facet procedures require image guidance with fluoroscopy or CT; ultrasound guidance alone or no guidance is noncovered.

COVERAGE CRITERIA AND MEDICAL NECESSITY
– Indications: Chronic moderate to severe axial neck or low back pain ≥3 months causing functional deficits and failed conservative care.
– Exclusion of radiculopathy or neurogenic claudication unless caused by facet cyst.
– No alternative explainable non-facet pathology per clinical and imaging assessments.
– Diagnostic facet procedures require sequential blocks confirming ≥80% pain relief before therapeutic procedures or RFA.
– Therapeutic injections require prior successful diagnostic blocks and documented contraindications for RFA (e.g. spinal pseudarthrosis, implanted electrical device).
– Repeat diagnostic procedures allowed after minimum 2-week interval; repeat therapeutic injections require ≥50% pain relief or functional improvement lasting ≥3 months.
– RFA repeat allowed after ≥6 months with ≥50% pain or function improvement.
– Facet cyst aspiration/rupture requires imaging-confirmed nerve root compression from cyst and corresponding symptoms; repeat once per cyst if ≥50% pain relief for ≥3 months.

BILLING, CODING, AND MODIFIERS
– Use CPT/HCPCS codes per AMA CPT Manual guidance.
– Append modifier 50 for bilateral interventions.
– Use KX modifier on all diagnostic injections to indicate medical necessity documentation; inappropriate KX use may trigger medical review.
– Report only one unit per joint for RFA codes regardless of number of nerves treated.
– Same day multiple facet and other spinal blocks discouraged; if performed must have documented medical necessity to avoid denials.
– Claims require valid ICD-10 diagnosis best describing condition; incomplete or missing diagnosis codes cause claim return per Social Security Act Section 1833(e).
– CPT 64999 for non-thermal facet denervation or injection with biological substances is noncovered.

ANESTHESIA AND SEDATION
– Moderate or deep sedation, general anesthesia, and monitored anesthesia care (MAC) are generally not medically necessary for facet injections.
– Moderate sedation or MAC may be considered for RFA or cyst rupture only with documented medical necessity (e.g. inability to cooperate), excluding anxiety or preference alone. Frequent use may prompt medical review.

DOCUMENTATION REQUIREMENTS
– Document baseline and post-procedure pain and disability assessments using consistent, validated scales (e.g. NRS, VAS, Oswestry Disability Index).
– Medical record must include patient assessment, relevant history, test/procedure results, signed and dated office or operative notes.
– Document medical necessity for all treatments and reasons for contraindications to preferred interventions like RFA.
– Document anatomic restrictions preventing medial branch blocks if IA injections are performed diagnostically.
– Documentation must demonstrate absence of alternate causes and appropriateness of procedure per coverage criteria.

DENIAL RISKS AND COMMON AUDIT TRIGGERS
– Facet interventions without appropriate imaging guidance or done under ultrasound guidance only.
– Injection of biologics or non-FDA designated substances.
– Thermal and non-thermal facet denervation coding errors (e.g. using CPT 64999 for non-thermal).
– Multiple blocks on same day without clear medical necessity.
– Procedures exceeding allowed levels or multiple spinal regions in one session.
– Lack of documentation supporting pain relief thresholds or failure of conservative therapy.
– Absence of valid, specific ICD-10 diagnosis code or use of generalized pain diagnoses like fibromyalgia alone.
– Use of sedation without documented medical necessity.
– Facet joint procedures performed after anterior lumbar interbody fusion (ALIF).
– Repeat diagnostic injections without appropriate time interval or criteria met.

PROVIDER QUALIFICATIONS
– Procedures must be performed by providers appropriately trained and credentialed via formal residency/fellowship, board certification, or accredited post-graduate training programs.
– Providers must have documented proficiency in anatomy, pharmacology, disease management, procedure technique, and imaging guidance utilization.
– Non-physician providers may certify orders within their state scope of practice per CMS and Social Security Act rules.
– Hospital credentialing for procedures must align with outpatient credentialing if services performed outside hospital settings.

FREQUENCY LIMITS
– Diagnostic facet joint injections: maximum 4 sessions per spinal region per 12-month rolling period.
– Therapeutic facet joint injections: maximum 4 sessions per spinal region per 12-month rolling period.
– Radiofrequency ablation: maximum 2 sessions per spinal region per 12-month rolling period.
– Facet cyst aspiration/rupture repeat limited to once per cyst with requisite pain relief duration.

NOT CLEARLY STATED IN SOURCE
– Specific ICD-10 codes for syringeable injections are not defined beyond general coverage of facet-related dorsopathies.
– Explicit prior authorization requirements not detailed.
– Specific billing instructions for claims involving multiple providers or facilities beyond ASC modifier 50 guidance.